ACTU

Actuate Therapeutics · USD

Market open US (NYSE / Nasdaq) · 09:30–16:00 · Mon 15:40 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About Actuate Therapeutics

Actuate Therapeutics (ACTU) is a biotechnology company focused on developing novel therapies for rare diseases, with a particular emphasis on gene therapy and cell therapy approaches.

HealthcareBiotechnologyPharmaceuticals

Ticker	ACTU
Name	Actuate Therapeutics
Currency	USD
Sector	Healthcare

Reputation

😎

How liked 50/100

From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

…

good bad neutral closed

Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

BEARISH

24.39

RSI (14)i

2.06

SMA 20i

2.38

SMA 50i

4.93

SMA 200i

0.83%

1di

-3.19%

1wi

-37.24%

1mi

4.51%

30d voli

8.72

52w highi

1.72

52w lowi

-79.13%

from highi

-0.21

MACDi

Downtrend (50d below 200d)Oversold (RSI 24)MACD bearish crossover

Computed from 257 locally-stored price bars.

AI signals

HOLD 70% · long_term 2026-06-08 10:10

The stock has been in a downtrend with significant losses over the past week, and there are no recent positive news to counterbalance this. The price action suggests continued weakness without any clear signs of bottoming or reversal.

qwen2.5:3b